Analyst Ratings for Enanta Pharmaceuticals (ENTA)
ENTA Rating Summary
ENTA Price Target Summary
- Highest: $24.00 (WestPark Capital)
- Lowest: $9.00 (Leerink)
- Average: $18.86
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$18.86 (+39.6%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
Avg. $ Target:
$18.86 (+39.6%)
* Over Last 12-Mos
Rating Score: 7.9 / 10
Percentile Rank: 82%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/26/2026 | Rodman & Renshaw | Seema Sheoran | New Coverage | Buy (N/A) |
20.00 (N/A) |
12.17 (13.51) |
11.01% | Details |
| 11/14/2025 | JPMorgan » Updated 3/3/2026 |
Anupam Rama | New Coverage | Overweight (N/A) |
19.00 (17.00) |
11.93 (13.51) |
13.24% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
